In the documentary “In Waves and War,” directors Jon Shenk and Bonni Cohen shed light on the harrowing experiences of Navy SEALS who endure rigorous training and multiple deployments to combat zones, only to return home and face a different kind of battle – one that takes a toll on their bodies and minds. The film follows the journeys of Marcus Capone, Matty Roberts, and DJ Shipley, showcasing the physical and psychological impacts of their service.
Roberts, who lost his arm in combat and suffered from traumatic brain injury and PTSD, struggled with survivors’ guilt and frustration. Shipley, deployed on nearly 200 missions, battled depression and memory loss in silence for years. These experiences are all too common among veterans, as I have witnessed in my own practice as a physician.
The mental health crisis among veterans is staggering, with high rates of PTSD, depression, anxiety, substance use disorders, and suicide. Despite available treatments, many veterans do not receive the care they need. This is where experimental treatments like ibogaine come in.
After years of suffering, Capone’s wife discovered a program in Mexico that offered ibogaine and 5-MeO-DMT treatments. These psychedelic substances have shown promise in treating mental health issues, including PTSD and depression. The Navy SEALS featured in the documentary underwent this treatment and experienced profound changes in their outlook on life.
Dr. Nolan Williams, a psychiatrist and researcher, highlights the potential of ibogaine in treating veterans with traumatic brain injuries. His team’s research has shown significant reductions in PTSD, depression, and anxiety in special forces veterans who underwent ibogaine treatment.
While psychedelic substances like ibogaine remain classified as Schedule I drugs in the U.S., the experiences of these Navy SEALS offer a glimmer of hope for those struggling with the invisible wounds of war. As more research is conducted and awareness grows, there is potential for these treatments to become more widely available to those who need them. Three Navy SEALs recently traveled to Mexico for a unique treatment involving ibogaine and 5-MeO-DMT. Over the course of five days, they underwent a transformative experience that allowed their traumatic pasts to come to life through personalized animation. Each SEAL was closely monitored by staff throughout the treatment process, ensuring their safety and well-being.
The results were profound for each individual. They all expressed feeling uplifted and as if a weight had been lifted off their shoulders. The psychedelics provided them with a new perspective on life, free from the burdens of guilt, shame, loneliness, and depression. One SEAL described it as a “new day,” symbolizing a fresh start and renewed sense of hope.
The use of psychedelics for therapeutic purposes is not a new concept. Scientists have long recognized the potential health benefits of substances like ibogaine, which can be used to manage conditions such as depression, addiction, and psychological trauma. However, in the United States, regulatory hurdles pose a significant challenge to widespread access to these treatments.
Ibogaine is classified as a Schedule I controlled substance, making it difficult for individuals to obtain and use it for therapeutic purposes. Additionally, the potential cardiac toxicity and other side effects of the drug necessitate its administration under medical supervision. Despite these challenges, there is a growing recognition of the potential benefits of psychedelic therapy for a wide range of conditions beyond just veterans, including survivors of trauma and natural disasters.
While more research and advocacy are needed to expand access to psychedelic therapy, there is reason for hope. The stories of these Navy SEALs and their families serve as a powerful reminder of the resilience of the human spirit in the face of adversity. By continuing to push for progress in the field of psychedelic therapy, we can help more individuals find healing and hope in their lives.
